| 【公司研究】三生制药 (1530 HK) - 辉瑞全速推进707全球临床，ADC联用蓄势待发 |
| 【Company Research】CR Beverage (2460 HK) - Leave the worst behind in 2025 |
| 【行业研究】中国医药 - 创新药出海BD仍然火爆，关注IO 2.0抢位赛 |
| 【Company Research】Ping An (2318 HK) - Banca fuelling NBV growth in jumpstart sales; 4Q earnings could ease on growth stock corrections |
| 【公司研究】康龙化成 (300759 CH) - 具备加速增长潜力的一体化CXO |
| 【Company Research】Pharmaron Beijing (300759 CH) - A one-stop CXO with accelerated growth potential |
| 【Company Research】iQIYI (IQ US) - 4Q25E preview: expect both revenue and earnings to recover in 4Q25 |
| 【Sector Research】Auto - Weak 4Q25 sales may lead to earning miss |
| 【Sector Research】Semiconductors - TSMC earnings: Cautious optimism confirmed by AI profitability |
| 【Sector Research】Capital Goods - Strong sales momentum continued for truck cranes & crawler cranes in Dec 2025 |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
